A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo. (2023)

First Author: Giannakopoulou E
Attributed to:  Understanding cell fate decisions in normal and abnormal haematopoiesis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s43018-023-00642-8

PubMed Identifier: 37783807

Publication URI: http://europepmc.org/abstract/MED/37783807

Type: Journal Article/Review

Volume: 4

Parent Publication: Nature cancer

Issue: 10

ISSN: 2662-1347